Postcards from Trondheim
I was privileged to spend 10+ days traveling to Copenhagen (Denmark), Lund (Sweden), and Trondheim (Norway). During my travels, I met with a number of emerging biotech companies, helped…
Menu
LUNCH: A Framework for Business Development
From a consulting perspective, here is how we view business development, using the acronym LUNCH: Learn what the client wants: What is the objective? Is it cash now in the…
The Keys to the Kingdom
There is a terrific article in Nature Biotechnology entitled Keys to the Kingdom. The article discusses a number of issues bioentrepreneurs may encounter when trying to license technology from a…
The Ten Year Venture Fund: A Thing of the Past?
Today's issue of Institutional Investor has an interesting article on the reality of 10-year venture funds. The author presents statistics demonstrating that <10% of ten-year venture funds actually liquidate…
Venture Funding of Therapeutic Innovation: An Important Report
Earlier this week, BIO released what we think is a valuable and important report. Entitled Venture Funding of Therapeutic Innovation, the report analyzes data on venture funding in R&D by…
The Class of 2014: Both Large and Innovative
Lisa Jarvis has prepared a handy overview of the new drug approvals in 2014: For the pharmaceutical industry, 2014 was one for the record books: sky-high merger and acquisition activity, unprecedented…
Finally, Some Sense
Today, Bruce Booth published yet another terrific post, where he discusses the current biotech investment bubble from the private world of venture backed biotechs (and, he puts many mainstream journalists…
The Annual SFO Kickoff Conference/Party/Thing at #JPM15 #BTS15
It's hard to believe that a week has passed since we were dashing from meeting to meeting in San Francisco. We conducted 29 scheduled meetings at the Biotech Showcase,…
Final Thoughts before #BTS15 and #JPM15
The decks have been prepared, edited, and uploaded to the cloud. The meeting schedule is finalized. The objective of each meeting is clear. Air, hotel, and ground transportation is all…
The Life Sciences in Wyoming – Part Three of Three
In Part One of his series, Dr. Garrett Lindemann discussed some of the challenges facing Wyoming as it grows its life science industry. In Part Two of this series, Dr. Lindemann highlights some of…
- Go to the previous page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- …
- 33
- Go to the next page